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 Lis1 haploinsufficiency in humans results in a “smooth brain” phenotype 
called lissencephaly, and also causes severe cognitive and motor impairments 
and epilepsy. Seizure severity and frequency typically worsens with time; patients 
often die within the first decade due to seizure-induced aspiration and 
pneumonia. Various mouse models have been used to examine the role of Lis1 
during brain development, and it is clear that Lis1 regulates a microtubule motor, 
cytoplasmic dynein. Intriguingly, Lis1 expression remains high in adult brains 
indicating that it plays a role in mature systems. Indeed, our group found that Lis1 
and several related proteins regulate dynein-dependent axon transport in 
cultured adult rat sensory neurons. Here, we hypothesize that loss of Lis1 in adult 
mice could lead to neurological disorders or other diseases. 
 In order to bypass the developmental impact of Lis1 loss, we first utilized a 
tamoxifen inducible Cre-mediated recombination system driven by an actin 
promoter to knock out Lis1 in adult mice (>8 weeks). We found that loss of Lis1 in 
adult mice caused a progressive decline and ultimately death. These phenotypes 
were not observed in any of a variety of control animals. Analysis of Cre activity 
revealed it was not uniformly stimulated in all regions of the brain, and is highest 
in the brainstem, where neuronal processes in regions known to control 
cardiorespiratory networks were activated. In non-neuronal tissues, high level of 
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Cre activity was also detected in the hearts of tamoxifen induced Lis1 knockout 
mice. 
 Secondly, to determine whether the lethal phenotype is caused by loss of 
Lis1 in brainstems or in hearts, we generated a cardiomyocyte-specific inducible 
lis1 knockout mouse model. Deletion of lis1 in hearts did not seem to induce 
lethality or malaise in adult mice. This strengthened the hypothesis that the death 
phenotype may be caused by Lis1 loss in neurons of the cardiorespiratory 
brainstem network. 
 Lastly, examination of brain sections of experimental mice revealed 
hallmarks of chromatolysis. Cultured DRG neurons from adult tamoxifen injected 
experimental animals, but not controls, showed signs of axon pathology and 
transport defects. Together, our results indicate that Lis1 is essential for adult 
mammalian system, and its loss of function causes lethal phenotype in adult 
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 Lissencephlay is a severe brain developmental disorder, which is also 
known as “smooth brain”. In patients with this disease, most of the cerebral 
cortex lacks the grooves and gyrus as a normal brain does. Disorganization of 
cerebral layers results in devastating consequences- defective cortex function 
and early death, usually from worsened seizures.  
Lis1 and brain development 
Type I lissencephaly has been attributed to sporadic mutation in the 
human LIS1 gene. LIS1 was identified as a subunit of a brain cytosolic isoform of 
platelet-activating factor (PAF) acetylhydrolase. The first invertebrate LIS1-
related gene identified was nudF in the mold Aspergillus nidulans. Mutations in 
nudF caused a severe defect in the migration of nuclei into and within the hyphal 
processes, resulting in reduced colony size. This evidence suggested a 
corresponding function for LIS1 in brain development. Nuclear migration occurs 
within the processes of proliferating neuroepithelial cells and also some 
differentiating neurons. Homozygous-null LIS1 mutant mice exhibited early post-
implantation embryonic lethality, suggesting a basic cellular role for LIS1. Mice 
with partial reduction of Lis1 displayed brain disorganization as well as cerebellar 
defects. Neuronal migration abnormalities were observed in Lis1 mutants both in 
vivo and in vitro(Hirotsune et al., 1998). These findings suggested LIS1 played a 
cell-autonomous neuron-specific role for neuronal migration.  The systematic 
examination of the consequences of dosage reduction of LIS1 in mice revealed 
defects in interkinetic nuclear migration and neuroblast proliferation(Gambello et 
al., 2003).  
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 In the hippocampus of Lis1+/- mice, synaptic transmission was severely 
disrupted, demonstrating hyperexcitability at Schaffer collateral-CA1 synapses 
and depression of mossy fiber-CA3 transmission(Fleck et al., 2000). A significant 
alteration in function of inhibitory circuits was found within the malformed Lis1+/- 
hippocampus. These hippocampal defects could provide a neuronal mechanism 
for seizures associate with lissencephaly(Jones and Baraban, 2007). It is shown 
that Lis1 haploinsufficiency can lead to abnormal cell proliferation, migration and 
differentiation in the adult dentate gyrus(Wang and Baraban, 2007). Lis1 
heterozygous mice also displayed abnormal motor behavior and spatial learning 
and memory(Paylor et al., 1999).  
Lis1/Dynein/Nudel Complex 
It is demonstrated that Lis1 directly interacts with the cytoplasmic dynein 
heavy chain (DHC) and Nudel, a murine homolog of the Aspergillus nidulans 
nuclear migration mutant NudE(Niethammer et al., 2000). Lis1 and Nudel were 
found to regulate the distribution of DHC along microtubules. The 
Lis1/Nudel/DHC complex is seemed to be involved in retrograde axon transport 
in the adult. This complex may play important roles of cell proliferation, cell 
survival and/ or degeneration(Sasaki et al., 2000). It is speculated that disruption 
in the Lis1/Nudel/DHC complex may result in functional impairment of axonal 
transport, which could be responsible for neurological impairment in the 
devastating disease.  
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Roles of Lis1 in cellular functions 
Our group found that Lis1 in enriched in neurons relative to levels in other 
cell types. Lis1 interacts with the microtubule motor cytoplasmic dynein and may 
stimulate specific dynein functions in neuronal migration and axon growth(Smith 
et al., 2000). Dynein and Lis1 play an important role in microtubule advance 
during growth cone remodeling associated with axonogenesis(Grabham et al., 
2007). Besides its role in brain development, Lis1 is also involved in other cellular 
functions. Overexpression of Lis1 in cultured mammalian cells interferes with 
mitotic progression and leads to spindle misorientation (Faulkner et al., 2000). 
Lis1 has also been implicated in dynein-mediated nuclear migration in various 
organisms(Xiang, 2003). Overexpression of dominant negative dynactin and Lis1 
interfered with the rate of cell migration(Dujardin et al., 2003). 
There has been controversy over how Lis1 mediates dynein-dependent 
transport. One group showed that inhibition of Lis1 impaired anterograde 
movement of cytoplasmic dynein(Yamada et al., 2008). Other group reported that 
Lis1 inhibition had little effect on lysosomes but greatly inhibited axonal transport 
of large, but not small vesicles(Yi et al., 2011). Our group previously reported that 
Lis1 overexpression stimulated retrograde transport, while Lis1 RNAi significantly 
reduced axon transport of lysosomes moving in axons of adult rat sensory 
neurons(Pandey and Smith, 2011b). Also, depletion of Lis1 suppressed 
mitochondrial motility in both anterograde and retrograde directions(Shao et al., 
2013).  
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Axon transport and adult-onset neurodegenerative diseases (AONDs) 
Axonal defects have been identified in mouse model of Alzheimer’s 
disease. In this model, reduction of kinesin motor impaired axon transport 
enhanced the frequency of axonal defects and increased amyloid-beta peptide 
level (Stokin et al., 2005). Defective axonal transport of mitochondria was 
observed in a mouse model of Alzheimer’s disease(Calkins et al., 2011). Axonal 
transport deficits were found in an ALS mouse model(Bilsland et al., 2010).  
Adult-onset neurodegenerative diseases are a group of neurological 
disorder characterized by a progressive, age-dependent decline in neuronal 
function and loss of selected neuronal populations. Many major AONDs including 
Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis 
(ALS), display axonal pathologies including abnormal accumulations of proteins 
and organelles(De Vos et al., 2008). Deficits in axon transport have been 
documented in most AONDs, which commonly result in altered synaptic function 
and axonal connectivity in these diseases(Morfini et al., 2009). A mouse model 
postnatally deficient for proteins presenilin (PS) and expressing wild-type human 
tau exhibited early tau pathology and axonal transport defects, which were 
associated with reduced neurotrophin signaling, defective learning and memory 
and impaired synaptic plasticity(Peethumnongsin et al., 2010). Mutations in !-
synuclein (!-Syn) cause Parkinsons’ disease (PD). Mutant mice expressing high 
levels of A53T human !-Syns developed adult-onset neurodegenerative disease 
with a progressive motor dysfunction leading to death(Lee et al., 2002). In A53T 
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mice, neurons in brainstem and spinal cord exhibited large axonal swelling, 
somal chromatolytic changes, and nuclear condensation(Martin et al., 2006).  
 
Lis1 knockout mouse models 
 Homozygous-null Lis1 mice are lethal at E7, while deletion of a single 
allele of Lis1 exhibited hippocampal abnormalities, loosely paced granule cells 
and neuronal migration abnormalities(Hirotsune et al., 1998). Multiple doses of 
Lis1 had defects in interkinetic nuclear migration and neuroblast 
proliferation(Gambello et al., 2003). Lis1+/- mice showed adult hippocampal 
neurogenesis, abnormal cell proliferation, migration and differentiation in the 
adult dentate gyrus(Wang and Baraban, 2007). Lis1fl/fl;Pax2-Cre mice that had 
Lis1 deletion in midbrain-hindbrain E8 did not survive past 0. Lis1fl/fl;Wnt-Cre 
mice had neuronal loss with embryos dead E13.5. Lis1fl/fl;hGFAP Cre mice that 
had Lis1 deletion in neuronal precursor cells of the neocortex and hippocampus 
at E12.5-13.5 survived to P5, but missing the hippocampus. They also had 
defects in apical spindle orientation in the ventricular zone (Yingling et al., 2008).  
Lis1fl/fl;K14-Cre mice showed epidermal barrier function in desmosomes, which 
resulted in perinatal lethality(Sumigray et al., 2011). Adolescent (4weeks) 
Lis1+/fl;CamKCre mice exhibited deficits in social interaction and dendritic 
protrusion density(Sudarov et al., 2013).  
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Cardiorespiratory control network  
In this study, we utilized a tamoxifen inducible Cre-mediated recombination 
system to determine if loss of Lis1 in adult mice could result in any neurological 
diseases. We found out Lis1 depletion in adult mice leads to progressive decline 
and ultimate death. We speculate that this death phenotype could be due to 
defects in cardiorespiratory network in brainstem, which controls heart rate and 
breathing. Medulla oblongata is located in lower part of the brainstem, which 
carries out life sustaining function such as breathing, swallowing and heart rate. 
The pons sits directly above the medulla, connecting upper and lower parts of the 
brain. A network of neurons located within the brainstem are involved in 
regulating cardiorespiratory activity(Smith et al., 2007). The circuitry is located in 
the dorsal respiratory group and ventral respiratory column(VRC) of the medulla 
oblongata as well as in the dorsolateral pons(Bianchi et al., 1995) (Feldman et al., 
2003; Richter and Spyer, 2001). Cardiac vagal pre-ganglionic neurons of the 
nucleus ambiguous receive inhibitory inputs during inspiration as well as 
excitatory inputs during post-inspiration(Feldman and Del Negro, 2006). The 
VRC is responsible for generating the respiratory rhythm. Retrotrpezoid nucleus 
group and pre-Botzinger complex have been identified as principal components 
of rhythm generation(Feldman and Del Negro, 2006; Feldman et al., 2003). 
Neuronal circuits within the medullary pre-Botzinger complex generates the basic 
rhythm of breathing, and then relay the respiratory pattern to cranial and spinal 
motor neurons controlling respiratory muscles(Eisele and Jain, 1971; Hayashi 
and McCrimmon, 1996). The vagus nerve is controlling the heart. Cardiac vagal 
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pre-ganglionic motoneurons are located in dorsal vagal motonucleus and within 
the nucleus ambiguous of the medulla oblongata(Jones, 2001; Spyer, 1994). 
Inhibition of cardiac vagal motoneurons allows stimulus that enhances inspiration 
increases heart rate, while inputs that suppress ventilation or prolong expiration 
lower heart rate via cardiac vagal activation(Hyland et al., 2001).  
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CHAPTER 1 




 Our lab has previously demonstrated that perturbing Lis1 and its 
regulators impacts dynein-dependent transport of lysosomes and mitochondria in 
mature sensory neurons(Pandey and Smith, 2011a). Disruption in Lis1 regulatory 
pathway could contribute to worsening lissencephaly symptoms, and may be 
relevant to other neurological disorders.  
 It is difficult to determine how Lis1 pathways function in the mature 
nervous system because Lis1 is so important in embryonic development. In order 
to bypass the embryonic impact observed in conventional Lis1 knockouts, Lis1 
should be removed from mature neurons. However, in cultured sensory neuronal 
system, removing neurons to tissue culture can recapitulate developmental 
programs rendering the neurons distinct from those in the intact animal. We 
therefore generated a tamoxifen-inducible Cre mouse homozygous for a floxed 
Lis1 allele. In this way Lis1 can be silenced at a chosen time after major 
developmental processes have taken place. This not only allows us to determine 
the importance of Lis1 in mature neuron, it provides a model for potential 
therapeutic intervention to counteract symptoms of lissencephaly that may arise 
post-developmentally as a result of transport defects. 
 Conditional Lis1 knockout was accomplished by inducing Cre-mediated 
recombination post-developmentally to delete a floxed region of the Lis1 gene. 
Lis1 is most abundantly expressed in nervous system while its expression is very 
low in non-neuronal tissues, thus, we chose to use ! actin-driven promoter Cre to 
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ensure all neurons lose Lis1. Also, it would give the best chance of observing a 
phenotype from an induced knockout and not restrict knock out to specific 
subsets of neurons. The caveat is that this approach would also knock out Lis1 in 
other adult tissues. However, as expression levels were much lower we expected 
to observe a brain phenotype, if any.  
 There strains of commercially available mice will be crossed to generate 
animals that are homozygous for a floxed Lis1 allele and hemizygous for an 
inducible Cre recombinase allele and a Cre-reporter allele. The cureent mouse 
model for lissencephlay, which carries a heterozygous deletion of Lis1 has 
substantially milder phenotype than humans with Lis1 haploinsufficiency. 
Although the Lis1 mutant mice appear to have slow or delayed neuronal 
migration with an onset near E17.5, Lis1 het mutants have no apparent gross 
phenotype compared to wild type mice except mild learning deficits in spatial and 
motor learning (Paylor et al., 1999). Our transport studies indicate that Lis1 
dosage can dramatically impact the number, speed, and run lengths of 
organelles moving retrogradely in axons, and we suspect this contributes to 
increased pathology in the longer human axons. Therefore, a homozygous 
knockout of Lis1 serves the best model to study the impact of Lis1-dependent 
transport defects in mice. On the other hand, the mild phenotype in the current 
developmental model may be caused by compensatory mechanisms arising 
because of the early loss of Lis1. If this is the case, knocking out a single allele in 
mature neurons could result in a more severe adult phenotype. We are able to 
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examine the impact of both heterozygous and homozygous conditional Lis1 
knockouts and determine the effect neuronal survival, morphology and function. 
 
1.2 MATHODS AND MATERIALS: 
1.2.1 Animals: The three mouse strains used to generate inducible Lis1 
knockout mice were purchased from Jackson lab(Figure 1.1).  
a) Lis1+/fl (or 129S-Pafah1b1tm2Awb/J-JAX#008002): These mice possess 
loxP sites flanking targeting vector containing PGKneo. This construct was 
electroporated into 129S6/SvEvTac derived TC-1 embryonic stem (ES) 
cells. Correctly targeted ES cells were injected into recipient blastocysts. 
Mice that are homozygous for this allele are viable, fertile, normal in size 
and do not display any gross physical or behavioral abnormalities. When 
these mutant mice are bred to mice that express Cre recombinase, 
resulting offspring will have exons 3 through 6 deleted in the cre 
expressing tissue(s).  
b) Cre-ERTM (or Tg(CAG-cre/Esr1*)5Amc/J-JAX #004453): These transgenic 
mice have a tamoxifen-inducible cre-mediated recombination system 
driven by the chicken beta actin promotor/enhancer coupled with the 
cytomegalovirous (CMV) immediate-early enhancer. The transgene insert 
contains a fusion product involving Cre recombinase and a mutant form of 
the mouse estrogen receptor ligand-binding domain. The mutant mouse 
estrogen receptor does not bind natural ligand at physiological 
 13 
concentration but will bind the synthetic ligand, 4-hydroxytamoxifen. 
Restricted to the cytoplasm, the Cre/ESR1 protein can only gain access to 
the nuclear compartment after exposure to tamoxifen. When crossed with 
a strain containing a loxP site flanked sequence of interest, the offspring 
are useful for generating tamoxifen-induced, Cre-mediated targeted 
deletions. Homozygous mice are not viable or fertile. Heterozygous mutant 
mice are viable, fertile, normal in size and do not display any gross 
physical or behavioral abnormalities. 
c) R26GT (Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J-Jax#007576): The 
mT/mG (membrane-Tomato/membrane-Green) targeting vector was 
designed with a CMV enhancer/chicken beta-actin promotor driving loxP-
flanked tdTomato protein sequence. An N-terminal membrane-tagged, 
enhance green fluorescent protein sequence is distal to the second loxP 
site. The entire mT/mG construct was inserted into the Gt(ROSA)26Sor 
locus via electroporation of (129X1/SvJ x 129S1/Sv)F1-derived R1 
embryonic stem(ES) cells. mT/mG homozygoutes can be identified by tail 
or whole body epifluorescence. When bred to Cre recombinase 
expressing mice, the offspring have the mT cassette deleted in the cre 
expressing tissues, allowing expression of the membrane-targeted EGFP 
(mG) cassette located just downstream. The CTB promotor allows 
stronger and persistent expression of the fluorescent proteins compared to 
the endogenous Gt(ROSA) locus alone. This double-fluorescent system 
allows direct live visualization of both recombined and non-recombined 
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cells at single cell resolution, offering an internal control for phenotypic 
analysis of Cre-induced mosaic mutants.  
 
1.2.2 Mouse breeding and colony maintenance 
 The University of South Carolina. The experimental protocols were 
approved by the Animal Use Protocol (AUP) committee. All the transgenic mice 
and knockout mice were maintained on its original genetic background. However, 
when generating inducible Lis1 knockout mice by crossing three different mouse 
strains, mixed genetic background could not be avoided. To minimize variation in 
the genetic background, the males (Lis1fl/fl;actin-CreERTM; R26GT) and females 
(Lis1fl/fl;R26GT) from the same generation were crossed to produce inducible Lis1 
knockout mice, and mice from the same litter were compared. However, in order 
to gather enough samples for statistical analysis, tissues from different animals 
with the same genotype at different ages were pooled.  
 Mice were marked by ear puncture at weaning (3-4 weeks old), and 
genomic DNA was extracted from tail for routine genotyping. 
1.2.3 Genotyping: 
 Mice tails were digested in Tail buffer plus Protease K overnight at 55 oC. 
2µl of tail digest was used as DNA templates for PCR reaction. Primers for Lis1 
flox/flox: Sequence5'->3' TGA ATG CAT CAG AAC CAT GC; CCT CTA CCA 
CTA AAG CTT GTT C. Primers for Cre : Sequence5'->3' CTA GGC CAC AGA 
 15 
ATT GAA AGA TCT; GTA GGT GGA AAT TCT AGC ATC ATC C. Primers for 
R26GT : Sequence5'->3' CTC TGC TGC CTC CTG GCT TCT; CGA GGC GGA 
TCA CAA GCA ATA ; TCA ATG GGC GGG GGT CGT.  
 A standard PCR reaction was set up as followed: For each tail DNA 
sample, to make 25µl total volume, 6.5µl of H2O, 5.5 µl Master Mix 2.5µl each 
primer and 2µl Tail DNA were added to PCR tubes. The reaction was performed 
on a PCR thermocycler as follows: 94oC for 3 min for hotstart; 94 oC for 30s, 60 
oC for 1 min, 72 oC for 1min. Repeat steps above for 35 cycles. 10µl of the 
reaction product was run on 5% polyacrylamide gel at 120V for 30 min. Gel was 
stained with EB for 10min. DNA bands could be detected under UV light. 
 
1.3 RESULTS: 
1.3.1 Verifying Lis1+/fl , actin-Cre ERTM, R26GT mice by PCR 
 Lis1+/fl, Lis1 fl/fl mice were confirmed by PCR reactions. After gel 
electrophoresis, we expected to see heterozygotes with a mutant band at 210 bp 
and a wild type band at 167 bp; homozygous with one mutant band at 210 bp; 
wild type with one band at 167bp(Figure 1.2B).  
 Heterozygous actin-Cre ERTM mice were identified by PCR using primers: 
Sequence5'->3' CTA GGC CAC AGA ATT GAA AGA TCT; GTA GGT GGA AAT 
TCT AGC ATC ATC C. A positive band at 100bp was identified as an actin-Cre 
ERTM mouse. A negative band indicated a wild type allele for actin-Cre ERTM 
gene(Figure 1.2C).  
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 R26GT mice were used a Cre reporter strain. It is reported that 
heterozygous R26GT is sufficient to identify red fluorescence without Cre 
recombination. Homozygous R26GT was detected with a single mutant band at 
250 bp on 5% polyacrylamide gel(Figure 1.2D). Heterozygous R26GT was 
identified with one mutant band at 250 bp and one wildtype band at 330bp. One 
single band at 330 bp indicated wild type alleles for R26GT. 
 
1.3.2 Summary of breeding strategy: 
 Heterozygous Lis1+/fl mice were intercrossed to produce Lis1 fl/fl 
mice(Figure 1.3). One quarter of the offspring were homozygous for floxed Lis1. 
Double floxed Lis1 mice were then crossed with Cre ERTM +/- mice to obtain 
heterozygous lis1 flox; Cre ERTM. Heterozygous floxed Lis1; Cre ERTM  mice were 
backcrossed with homozygous Lis1 flox mice. One quarter of the offspring were 
homozygous for Lis1 flox and heterozygous for Cre ERTM. Another quarter of the 
offsprings were homozygous Lis1 flox without Cre ERTM, which served as a 
control.  Tissues from these mice were harvested to examine levels of proteins of 
interest. 
 In order to generate inducible Lis1 knockout with Cre-reporter gene, 
homozygous Lis1 flox mice were crossed with homozygous R26GT reporter 
strain to obtain 1/4 offsprings carrying heterozygous Lis1 flox; R26GT. Lis1 
flox+/-; R26GT+/-  mice were then mated to produce homozygous Lis1 
flox;R26GT strain. This strain were backcrossed with homozygous Lis1 flox; 
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 Heterozygous Cre ERTM to generate homozygous Lis1 flox;Heterozygous 
Cre ERTM and R26GT stain. One half of the offspring were Homozygous Lis1 flox; 
heterozygous R26GT without Cre ERTM, which were used as controls.  
 Additionally, to obtain a Cre ERTM; R26GT control, Cre ERTM strain was 
bred with R26GT strain. Cre ERTM; R26GT controls are important as they carry a 
Cre recombinase that we would know if activation of Cre upon tamoxifen injection 
has any effect on mice phenotype. 
 In the analysis of Cre activation by reporter strain, homozygous and 
heterozygous R26GT mice were not distinguished for each tissue. R26GT was 
identified by tail epifluorescence. 
 
1.3.3 Cre induction by tamoxifen : 
We chose a tamoxifen inducible Cre system first described by Hayashi, S. 
& McMahon, A.P (Hayashi and McMahon, 2002b). In the initial characterization 
of these animals, Cre could be activated in various tissues including central 
nervous system and in cultured cells. The recombination efficiency is dose 
dependent. Multiple injections of as highest dose as 9mg of TM did not lead to 
any obvious change in the behavior of the mice. Triple crosses produced mice 
with homozygous floxed Lis1 alleles, one Cre-ER allele, and a Cre reporter 
generated by L. & Luo (Muzumdar et al., 2007). This reporter gene codes for 
both mTomato (red fluorophore) and GFP, but GFP is only produced if Cre 
becomes active (i.e., enters the nucleus in response to tamoxifen). Two different 
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control animals were also generated. The first control carries the floxed Lis1 
alleles, but not the Cre-ER allele. The second control carries the Cre-ER allele, 
but has wild type Lis1. A third control was a mock injection of the triple mutant 
animal(Figure 1.4). 
 Adult mice (2-5 months old) were exposed to tamoxifen by intraperitoneal 
(IP) injections. Different dosages of tamoxifen were used in the experiments with 
low dose 2mg/day for 5 days, median dose 4mg/day for 5 days or high dose 8mg 
/day for 2 days. It has been shown that increasing the dosage of tamoxifen 
injected in the animals increased the frequency of Cre recombination 24h post-
injection up to the maximum dose of 9mg of TM(Hayashi and McMahon, 2002a).  
It revealed that high dose of TM resulted in a more rapid and more efficient 
induction of recombination. The initial dosage of TM administered in adult mice 
was determined based on the universal protocol published from Jackson Lab. It 
states that 2mg of tamoxifen for 5 consecutive days is sufficient to drive Cre 
activation in adult mice. It is reported that increasing the dosage of tamoxifen 
injected and multiple rounds of injections would increase the efficiency of Cre 
recombination. However, in the initial Cre induction studies, the variation in 







 The original three mouse strains purchased from Jackson Lab were from 
different genetic backgrounds. When crossed them to generated inducible Lis1 
knockout mouse model, the mixed background was obtained from different types 
of matings. Different genetic backgrounds may influence the phenotypes of the 
Lis1 inducible knockout mice.  However, we selected the experimental and 
control animals from the same litter to remove the side effects of different genetic 
backgrounds. When a R26GT reporter strain was introduced, it allowed a direct 
visualization of a fluorescent mouse. A single allele of R26GT is sufficient to 
detect tail fluorescence(Muzumdar et al., 2007).  
 At least 8 weeks old mice were chosen as adult mice because this is when 
mouse brain is fully developed and suited for study in adult system. Whether 
older mice will respond to TM induction differently besides the weight than young 
mice is unknown.  It has been a concern that the blood-brain barrier would 
prevent access of the drug. However, it has been shown that intraperitoneal 
injection of TM (3mg/day for 5 days) resulted in efficient Cre recombination 
including the brain(Hayashi and McMahon, 2002a).  Examination of tissues 
revealed the rapid onset of mG labeling within 24h following Cre 
induction(Hayashi and McMahon, 2002a). However, there is a concern regarding 
the lag between GFP expression and Lis1 knockdown. GFP expression may not 
provide an accurate measure of Lis1 knockdown. Therefore, reduction of Lis1 
protein expression level in specific tissues needs to be evaluated by western blot.  
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 This inducible knockout system can be used to remove activity of a gene 
of interest at a certain stage of postnatal development. This approach would 
allow us to overcome the developmental effects associated with germ-line 
ablation. However, a certain gene may play several different roles in different 
tissues at the same stage. Therefore, a tissue-specific Cre line may be 
introduced to knock out the gene in a certain tissue. In this case, alternatively, 
brain specific Cre mouse strain can be used to knock out Lis1 in central nerve 
system.  
 In the course of generating double Lis1 knockout mouse model, a 
heterozygous inducible Lis1 knockout was also generated. It will be valuable to 






















Figure 1.1 The three mouse strains used to generate inducible Lis1 
knockout mice. A.) Cre-ERTM: These transgenic mice have a tamoxifen-
inducible cre-mediated recombination system driven by the chicken ! actin 
promotor/enhancer. The transgene insert contains a fusion product involving Cre 
recombinase and a mutant form of the mouse estrogen receptor ligand-binding 
domain. B.) R26GT reporter: These mice possess loxP sites on either side of a 
membrane-targeted tdTomato(mT) cassette and express strong red fluorescence 
in all tissues. mT/mG homozygotes can be identified by tail or whole body 
epifluorescence. When bred to Cre recombinase expressing mice, the offspring 
have the mT cassette deleted in the cre expressing tissues, C.)Lis1+/fl These 
mice possess loxP sites flanking targeting vector containing PGKneo. When 
these mutant mice are bred to mice that express Cre recombinase, resulting 








Figure 1.2 Mouse breeding and colony maintenance.  
A.) Heterozygous Lis1+/fl mice(LlCCTT) were mated to produce Lis1 fl/fl mice. 
One quarter of the offspring were homozygous for floxed Lis1. Homozygous 
R26GT reporter(LLCCtt) mice were intercrossed to maintain the line. 100% of the 



























Figure 1.2 Mouse breeding and colony maintenance.  
B.) Lis1+/fl, Lis1 fl/fl mice were confirmed by PCR reactions. After gel 
electrophoresis, we expected to see heterozygotes with a mutant band at 210 bp 
and a wild type band at 167 bp; homozygous with one mutant band at 210 bp; 
wild type with one band at 167bp. Heterozygous actin-Cre ERTM mice were 
identified by PCR. A positive band at 100bp was identified as an actin-Cre ERTM 
mouse. A negative band indicated a wild type allele for actin-Cre ERTM gene. 
\Homozygous R26GT was detected with a single mutant band at 250 bp on 5% 
polyacrylamide gel. Heterozygous R26GT was identified with one mutant band at 
250 bp and one wild-type band at 330bp. One single band at 330 bp indicated 














Figure 1.3 Summary of breeding strategy. Heterozygous Lis1+/fl mice(LlCCTT) 
were mated to produce Lis1 fl/fl mice (llCCTT). One quarter of the offspring were 
homozygous for floxed Lis1. Double floxed Lis1 mice were then crossed with Cre 
ERTM +/- mice to obtain heterozygous lis1 flox; Cre ERTM. Heterozygous floxed 
Lis1; Cre ERTM mice(LLCcTT) were backcrossed with homozygous Lis1 flox mice. 
One quarter of the offspring were homozygous for Lis1 flox and heterozygous for 
Cre ERTM(llCcTT). Another quarter of the offsprings was homozygous Lis1 flox 
without Cre ERTM, which served as a control. In order to generate inducible Lis1 
knockout with Cre-reporter gene, homozygous Lis1 flox mice were crossed with 
homozygous R26GT reporter strain(LLCCtt) to obtain 1/4 offsprings carrying 
heterozygous Lis1 flox; R26GT(LlCCTt). Lis1 flox+/-; R26GT+/- mice were then 
mated to produce homozygous Lis1 flox; R26GT strain(llCCtt). This strain was 
backcrossed with homozygous Lis1 flox; Heterozygous Cre ERTM to generate 
homozygous Lis1 flox; Cre ERTM and R26GT strain(llCcTt). One half of the 
offspring were Homozygous Lis1 flox; heterozygous R26GT without Cre 
ERTM(llCCTt), which were used as controls. To obtain a Cre ERTM; R26GT 














Figure 1.4 Experimental animals and Cre induction. Triple crosses produced 
mice with homozygous floxed Lis1 alleles, one Cre-ER allele, and a Cre reporter 
(lis1fl/fl;actCreERTM;R26GT). Cre is activated by TM injection. Three different 
control animals were also generated. The first control carries the floxed Lis1 
alleles, but not the Cre-ER allele (lis1fl/fl; R26GT). The second control carries the 
Cre-ER allele, but has wild type Lis1(actCreERTM;R26GT). A third control was a 












 Lis1, the disease-causing gene for a “smooth brain” phenotype in which 
regions of the cortex of lissencephaly patients are smooth in appearance 
because of reduced or absent sulci and gyri. Children with lissencephaly have 
severe mental retardation and other severe neurological abnormalities. They 
often have feeding problems and hypotonia.  A large majority of patients have 
seizures during the first year.  Patients often die due to status epilepticus or 
pneumonia(Dobyns et al., 1993).  
Neurons extend long processes, requiring efficient transport mechanisms 
to allow communication of survival signals from the distal axon to the cell body 
(Levy et al., 1985; Perlson et al., 2010). Anterograde axon transport plays a role 
in supplying proteins and energy to the distal end, whereas retrograde transport 
is involved in the clearance of misfolded and aggregated proteins form the axon 
to the soma (2013).Retrograde axon transport is carried out by the multi-subunit 
motor protein complex cytoplasmic dynein(Schnapp and Reese, 1989).  
 Defects in dynein-dependent axon transport have been linked to 
psychiatric disorders and adult-onset neurodegenerative diseases. These 
diseases are often characterized by cell body inclusions, axonal swellings, and 
axon terminal degeneration(De Vos et al., 2008; Zuccato et al., 2010). 
Huntington’s disease, a disorder of the basal ganglia, is caused by polyglutamate 
repeat expansions in the Huntingtin protein(Zuccato et al., 2010). Huntingtin 
interacts with dynein and the plus-end directed motor, kinesin(McGuire et al., 
2006). The Huntingtin-associated protein 1(HAP1) binds to mutant Huntingtin, 
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and to dynactin, a dynein regulatory complex(Engelender et al., 1997; Li et al., 
1998). Phosphorylation of Huntingtin by the Akt/PKB kinase pathway in response 
to IGF-1/PI3K signaling may cause a switch from dynein to kinesin binding to 
influence the direction of vesicle transport(Caviston and Holzbaur, 2009; 
Hafezparast et al., 2003; McGuire et al., 2006). Recently basal ganglia defects 
were reported in a mouse with a point mutation in dynein heavy chain (the 
catalytic subunit)(Braunstein et al., 2010). Finally, mutations in dynactin that 
cause cytoplasmic inclusions have been found in eight families with Perry 
Syndrome, a disorder characterized by early-onset Parkinsonism, depression 
weight loss and hypovertilation(Strom et al., 2008). Amyotrophic Lateral Sclerosis 
(ALS) and similar motor neuron disease are also linked to transport. ALS-like 
symptoms have been observed in mice with dynein point mutations, and dynein 
binds to a mutant form of superoxide dismutase (SOD1) found in familial ALS, 
resulting in the formation of large inclusions containing mutant SOD1(Laird et al., 
2008). A mutation in a subunit of dynactin was found in a family with a lower 
motor neuron disease, and expression of the mutant protein caused motor 
neuron disease in transgenic mice(Puls et al., 2003).  
Impairment of axonal transport has also been related to other 
neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, 
and several motor neuron diseases. Several studies reported that transgenic 
mice overexpressing wild-type or mutant amyloid precursor protein (APP)(Salehi 
et al., 2006), mutant presenilin1 (PS1) (Lazarov et al., 2007)or wild-type or 
mutant tau(Zhang et al., 2004) display axonal transport deficits and axonal 
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swelling. Amyloid plaques are composed of deposits of the amyloid-!-peptide, 
which is produced by cleavage of the APP by !-secretase and "-secretase, a 
multi-subunit protein complex in which PS1 or PS2 is the catalytic subunit.  
A recent study showed that Prickle, a mutation of which results in epileptic 
phenotypes observed in flies, mice, zebrafish, and humans, organizes 
microtubule polarity and influences both anterograde and retrograde vesicle 
transport in axons of Drosophila neurons. The seizure phenotype in prickle 
mutant flies is caused by enhancement of the anterograde transport. Additionally, 
they showed Prickle heterozygotes exhibit severely reduced vesicle transport, 
with loss of both alleles of Prickle showing a marked decrease in 
viability(Ehaideb et al., 2014).  This is the first link between defective axon 
transport and seizures. 
Although to date no links between Lis1 and Nudel have been proposed in 
ALS, huntington’s disease or other neurological disorders, our demonstration that 
both proteins play a role in retrograde axon transport of lysosomes and 
mitochondria in mature neurons, coupled with the continued expression in mature 
brains, suggests this possibility should not be ruled out, and loss of Lis1 post-
develpmentally could result in neurological disorders. 
We have generated an inducible Lis1 knockout mouse as described in 
Chapter 1. In this study, we first analyzed the behavioral consequences of loss of 
Lis1 post-developmentally in adult mice, given the evidence that Lis1 plays 
essential roles in many aspects of neuronal development such as neuronal 
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migration as well as axonal transport. We also examined cytological 
abnormalities that may indicate neuronal dysfunction in knockout animals. 
  
 
2.2 MATHODS AND MATERIALS 
 
TM injection and Cre activation 
To induce Cre-mediated recombination, tamoxifen (Sigma-Aldrich) was dissolved 
in corn oil (Sigma-Aldrich) at a concentration of 40mg/ml and administered to 2-5 
month-old Lis1fl/fl; CreERTM; R26GT at different dosages (2mg/d for 5days, 4mg/d 
for 5days, or 8mg/d for 2days) depending on the experiment settings. Water and 
food were available ad libitum. Experiments were performed on 2-5-month-old 
male and female littermates after tamoxifen administration. No significant gender 
differences were observed. 
 
Tissue preparation and Histology. 
Animals were deeply anesthetized with isofluorane administration and perfused 
transcardially with ice-cold PBS first, followed by 4% paraformaldhyde (PFA) in 
0.1M PBS, pH7.4. For whole-mount organ analysis, organs were isolated and 
imaged with a CCD camera mounted on a fluorescence microscope(Olympus). 
For cryosection preparation, brains, hearts, lungs, livers and other tissues were 
removed and postfixed in 2% PFA+15% sucrose solution prepared in PBS 
overnight and subsequently cryoprotected by incubation in 30% sucrose solution 
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for 3-4 hours at room temperature. The cryoprotected brains were submerged in 
OCT Compound solution  and quickly frozen in 2-methylbutane cooled in liquid 
nitrogen. Sagittal or coronal sections were cut at a 10-µm thickness on a cryostat 
(Leica) and stored at -80oC before used. Slides were washed three times with 
PBS, treated with DAPI (Molecular Probes), washed again, mounted in antifade 
reagent (Invitrogen) and imaged with fluorescience microscopy (Zeiss) or 
confocal microscopy (Leica).  
 
Immunoblotting 
The levels of Lis1 protein was evaluated in Lis1 CKO and age-matched control 
mice by immunoblotting. Mice were deeply anesthetized and decapitated, and 
the brains and other tissues were removed quickly and frozen on dry ice. Tissue 
samples were homogenized with Dounce’s homogenizers in ice-cold RIPA buffer 
with protease inhibitors . Crude homogenates were sat on ice for 20 minutes and 
then centrifuged at 20,000 g for 1 hour (4oC) to yield soluble supernatant and 
pellet fractions. Protein concentrations were measured by BCA assay (Thermo 
scientific) with bovine serum albumin as a standard. Protein samples were 
subjected to 10% SDS-PAGE and transferred to PVMF membrane. Blots were 
blocked with 5% nonfact dry milk with 0.1% Tween 20 in PBS and then incubated 
overnight at 4oC with antibody to Lis1 or dynein intermediate chain. After the 
primary antibody incubation, blots were washed and incubated with horseradish 
peroxidate-conjugated secondary antibody, developed with enhanced 




To quantify protein immunoreactivity, films were scanned and densitometry was 
performed using image J. Protein levels were expressed as relative optical 
density measurements. Immunodensities were normalized to control proteins.  
Quantifying chromatolysis and nuclear eccentricity 
Toluidine blue-stained sections were used as part of the structural analysis. A 
chromatolytic neuron cell body was taken as one where discrete patches of 
cytoplasmic basophilia (Nissl bodies) could no longer be resolved in the light 
microscope over more than half the area of the cell body cytoplasm. An eccentric 
nucleus was taken to be one where the distance from the center of the nucleus to 
the cell body periphery was less than the distance from the center of the nucleus 
to the center of the cell body. 
 
Primary mouse dorsal root ganglion (DRG) culture 
Primary DRG neuronal cultures were prepared based on the modified protocol for 
rat DRG culture. Mice were first perfused with sterile ice-old PBS to remove 
blood and proteases so that nerves can be easily pulled out. Removed the bones 
surrounds spinal cord and pull out dorsal roots. Dissected out Lumbar 5-6 DRGs 
and dissociated ganglions in Collagenase for 1 hour, followed by 15 minutes with 
0.05% trypsin (Invitrogen). Dissociated neurons were spinned through a 15% 
sucrose solution. Neurons were plated onto sterile german glass coverslips 





Neurons were plated onto 12mm coverslips in 24-well plates. Neurons were fixed 
in 4% paraformaldehyde followed by permeabilization with 0.1% Triton X-100 for 
5 min at room temperature. Nuclei were visualized with Hoechst  and 
coverslipswere mounted on glass slides using ProLong Gold Antiface reagent 
(Invitrogen). Neurons were observed using an inverted microscope (Axiovert 200, 
Carl Zeiss Inc.) equipped with Plan-Neo 100x/1.30 objective and a Plan-Apo 
63X/1.40 objective. Digital images were acquired using a charge-couple camera ( 
AxioCam HRm, Carl Zeiss Inc.) linked to AxioVision software (Version 4.7, Carl 
Zeiss Inc.).  
 
Fluorescence time-lapse microscopy 
After exposure to 100nM Lysotracker for 20minutes, coverslips were transferred 
into fresh medium containing 25mM Hepes, pH7.4, in a water-heated custom-
built microscope stage warmed to 37oC using an inverted microscope (Axiovert 
200,Carl Zeiss Inc.) equipped with C-Apo 63x/1.2 W/0.2 water-immersion 
objective. Digital images were acquired using a charge-coupled camera 
(AxioCam HRm, Carl Zeiss Inc.) linked to AxioVision software (version 4.7, Carl 
Zeiss Inc.). For tracking lysosomes labeled with Lysotracker-Red (Millipore Inc.) 
in axons, images were recorded for 2min at 0.5 second intervals. Each 





Analysis of organelle movement using Image J software 
To determine the proportion of organelles that moved in different directions or 
remained static, kymographs were generated from time-laspe movies using 
image J software (version 10.2) as described in miller and Sheetz,2006 (Miller 
and Sheetz, 2006). By convention the direction towards the cell body was always 
to the right, so lines that sloped toward the right at any point with a net 
displacement of >5µm were categorized as retrograde organelles. Lines that 
sloped toward the left >5µm at any time during the recording interval were 
considered anterograde organelles. Lines that showed less then 5µm lateral 




Microsoft Exel and GraphPad Prism software was used for all statistical analysis. 
A Student’s unpaired, two-tailed t-test, ANOVA or Turkey’s multiple comparison 
test were used to calculate P values for all datasets. Single standard errors 




Tamoxifen inducible actin-Cre-mediated knockout of Lis1 in adult mice 




In order to induce Cre activation in adult mice, high dose of tamoxifen 
(8mg/day for two consecutive days) was administrated on the animals to ensure 
high recombination efficiency (Table 2.1).  Adult triple mutant mice at 8-week old 
injected on two consecutive days with tamoxifen began to exhibit malaise on as 
early as the second day, with clearly ruffled coats and spinal kyphosis(Figure 
2.1A). They were hypoactive and exhibited leg clasping in tail suspension test. In 
the initial studies experimental animals died on day 3-5 after the first injection 
(n=11). Control mice without Cre with same amount of tamoxifen injection 
showed no signs of distress at any time, nor did the mock-injected experimental 
animals (n=10). In later studies, animals were euthanized on day 3-5 for tissue 
analysis, and to examine GFP and Lis1 expression in various tissues (n=21).  
Older mice (2-5 months) injected with the same amount of tamoxifen (8mg/day 
for 2 days) showed the same behavior changes and died within one week after 
initial tamoxifen injection (n=3). Older mice tend to exhibit severe malaise at later 
days compared to younger mice probably due to older mice weigh slightly more 
than young ones, thus the overal exposure to tamoxifen is less in older mice. In 
order to determine whether Cre activation by tamoxifen has effect on the 
observed phenotype, controls without floxed Lis1 (CreERTM;R26GT) injected with 
the amount of tamoxifen were examined and found to be normal, suggesting Cre 
activation itself does not cause adverse effects in mice (n=24). 
Similarly, lower dose of tamoxifen was also administered on adult mice to 
drive cre activation(Table 2.2). Adult triple mutant mice (8-week old) injected with 
2mg tamoxifen per day for 5 consecutive days did not exhibit apparent behavior 
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changes until day 5 and die eventually between day 9 -16(n=6)(Figure 2.1B). The 
slight difference in survival days is resulted from dose-dependent cre 
recombination as it is reported that 3mg tamoxifen leads to 50% cells undergoing 
a recombination event 24 h post injection while 9mg of TM results in up to 80% of 
cells within a tissue underwent recombination within 24h of TM injection. In total, 
35 experimental animals injected with tamoxifen died on day 3-7 or showed very 
severe malaise between days 3 and 5. Of 52 total control animals, none showed 
signs of malaise.  In later experiments, high dose of tamoxifen (8mgx2) was used 
to induce Cre activation to ensure high percentage of Cre recombination in mice, 
unless noted in the experiments. 
 
Cre activity is not uniformly stimulated in all regions of the brain, and is 
highest in the brainstem. 
The sudden death of these animals was unexpected, but suggested that 
either a vital brain function, or a vital function carried out by other organs, was 
perturbed by Lis1 knockout.  It was therefore critically important to determine 
where Cre was activated at 3-5 days after tamoxifen injection. Examination of 
green fluorescence of whole brains from perfused animals indicated that Cre was 
strongly active in the brainstem, and cerebellum(Figure 2.2). Much less GFP was 
apparent in the cerebral hemispheres at 3 days after tamoxifen. An adult triple 
mutant mouse with mock injection showed no green fluorescence background 
under the same exposure time. Brain from inducible Lis1 knockout mice injected 
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with high dose tamoxifen and sacrificed on 5th day showed stronger GFP in 
brainstem and cerebellum than it was injected with low dose tamoxifen and 
euthanized on the same day(Figure 2.3). No significant green fluorescence 
except a few cells were observed in cortex in high dose tamoxifen treated 
animals at 5 days after initial injection. 
This indicated that we could not easily ascribe the death of knock out mice 
to cortical malfunction due to Lis1 loss, although this remains formally possible if 
a knocking out Lis1 in a few cells could lead to death. However, the loss of Lis1 
in brainstem, known to be the seat of nuclei controlling to complex 
cardiorespiratory network, remained a distinct possibility. Saggital sections of an 
inducible Lis1 knockout brain revealed significant amounts of GFP were present 
in brainstem and midbrain(Figure 2.4 A,B). Scattered green cells were observed 
in cortex and cerebellum under low magnification. Activated fibers and axon 
projections were seen at pons under higher magnification(Figure 2.4 C,D). In 
order to determine whether and where neuronal cell bodies were activated in the 
brainstem, coronal sections of brains were used to identify the positions of 
activated neurons in these animals(Figure 2.4E). Confocal imaging of brainstem 
sections revealed that significant amounts of GFP were present in what appeared 
to be neurons in the brainstem(Figure2.4J), and also in neuropil and many fiber 
tracts, including cranial nerves(Figure 2.4F,H,I). Thus, it was likely that Cre was 
activated by tamoxifen in neurons that are located in cardiorespiratory control 
network. Analysis of tissue sections demonstrated that some astrocytes in the 
cortex and hippocampus and Bergman's glia in the cerebellum also expressed 
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GFP. These observations are generally consistent with original findings of 
R26GT mice, however, due to relative short period between Cre induction and 
analysis, Cre recombination by tamoxifen has not occurred in the majority of the 
cortex during the 2-day period. It is reported that cell bodies were less 
prominently labeled compared to cells expressing cytosolic EGFP in 
brain(Muzumdar et al., 2007).  
Lis1 expression level is reduced in brainstem of inducible Lis1 knockout 
mice 
To test whether Lis1 level is reduced in brain tissues of adult triple mutant 
animals upon tamoxifen injection, extracts of brainstem, cerebellum, and cortex 
from tamoxifen treated of both floxed Lis1 with Cre transgene and floxed Lis1 
without Cre mice were probed with polyclonal Lis1 antibody. Brain tissues were 
collected at 3 days after high dose tamoxifen injection. Lis1 expression level was 
found to be significant reduced in brainstems of floxed Lis1 with Cre animals 
compared to controls(Figure 2.5 A). No reduction of Lis1 levels in the cortex was 
detected from tamoxifen induced Lis1 knockouts at 3 days after initiation of 
treatment compared to floxed Lis1 without Cre. The changes of Lis1 levels in 
different brain parts are consistent with Cre activity indicated by the amount of 
GFP observed in tamoxifen treated Lis1 knockouts. As stated before, low dose 
tamoxifen treated experimental animals did not exhibit severe behavior 
abnormality until 7 days after initial treatment. We wanted to compare Lis1 
expression patterns in high dose tamoxifen treated Lis1 knockouts and low dose 
treated animals. Experimental and control mice induced with both doses of 
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tamoxifen were sacrificed on 5th day after the first injection and brain tissues were 
harvested on the same time point. Western blot demonstrated that Lis1 
expression level had not reduced on 5th day after low dose tamoxifen injection, 
while its level dramatically decreased at the same time point in high dose treated 
experimental animals(Figure 2.5B). Fluorescence images of low dose treated 
Lis1 knockout brains showed weak GFP in brainstem at 5 day after initial 
treatment(Figure 2.3H), while no significant reduction in Lis1 level was detected 
in brainstem at the same time point. This observation suggests that there is a 
latency between visualization of Cre activation by GFP and the actual Lis1 
protein knockdown.  
 
 
Examination of brain sections for hallmarks of chromatolysis. 
To determine the cytopathology associated with behavior abnormalities 
and regional Lis1 expression knockdown in brainstem in the inducible Lis1 
knockout mice, the brains from experimental and control mice were examined by 
Nissl staining. As we have seen Cre activity in axonal projections and neuropil in 
brainstem of animals treated with tamoxifen, we hypothesized that if lis1 
disruption causes axonal defects in brains, we were likely to detect 
neuropathology in the regions that had Lis1 reduction. Axon damage provokes a 
process termed chromatolysis, characterized by somal swelling, nuclear 
eccentricity, and reduced Nissl substance (ER and ribosomes). This response 
may be caused by the disruption of retrograde signaling. Touidine blue staining 
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was used to visualize somal swelling, nuclear position, and Nissl substance 
dispersal in brain tissue(Figure 2.6A). A Nissl body can be defined as any 
aggregate of ribosome ER that could be identified in the light microscope as a 
patch in the cytoplasm of Toluidine Blue-stained sections (Johnson et al., 1985).  
Brainstem sections were selected where nucleus ambiguus was present in the 
coronal sections according to the mouse brain atlas. Landmarks such as fourth 
ventricle and pyramus granular layers were used to identify the proper sections. 
Comparison were made from matched sections. Neurons were selected in the 
regions of nucleus ambiguus, and were scored as having nuclear eccentricity if 
the perpendicular distance from the NE to the somal edge at any point is less 
than half the perpendicular distance of the NE to the somal edge at any other 
point. We measured the ratios of nuclear to soma in inducible Lis1 knockout and 
control mice and found that experimental mice harboring floxed Lis1and Cre 
transgenes, had significant larger nucleus versus cytoplasm in brainstem (Figure 
2.6C). The ratio of nuclear area versus soma was ~0.5  in tamoxifen induced Lis1 
knockout (+Cre) compared to the ratio of ~0.2 in control mice (-Cre). Another 
conspicuous feature of tamoxifen treated experimental mice, was that nucleus of 
neurons in were displaced toward the periphery of the soma and the Nissl 
substance was significant reduced in the soma. We then quantified the 
percentage of nuclear accentricity based on the criteria described above.  
Tamoxifen induced Lis1 knockout mice showed as high as 40 percent of neurons 
having nuclear accentricity, while control mice had very few neurons (10%) 




Cultured DRG neurons from adult tamoxifen injected experimental animals, 
but not controls, show signs of axon pathology and transport defects.  
 Because of the strong physical and functional link between Lis1 and the 
molecular motor protein cytoplasmic dynein, we considered the possibility that 
Cre activation and subsequent Lis1 loss would result in axon transport 
perturbations. It is difficult to directly measure transport in the brainstem, so we 
turned to a culture system that we have used in the past to measure dynein-
dependent axon transport. Unlike most adult neurons, DRG neurons can be 
successfully removed from adult rats and maintained in tissue culture for long 
periods of time. These neurons extend only axon like processes with polarized 
microtubules so that retrograde transport is typically thought to be carried out by 
dynein. On the third day (the day after the 2nd tamoxifen injection) neurons were 
removed from experimental triple mutants and control animals (no Cre-ER allele) 
and plated onto laminin-coated coverslips. Only the experimental animals 
showed GFP fluorescence, while only mTomato fluorescence was detected in 
control cells(Figure 2.7A). After 24 hours, cultures were fixed and axons 
examined for morphological changes. Several differences were found between 
GFP positive axons in from floxed Lis1 animals and Tomato positive axons from 
floxed Lis1 animals with no Cre. First the length of axon segments between 
branch points was shorter for GFP axons were shorter(Figure 2.7B). Second 
there was an increase in the number of varicosities per branch point, and an 
overall increase in varicosities per mm of axon(Figure 2.7C,D). Varicosities were 
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often seen at axonal ends, indicating defects in axon transport.These swelling 
are hallmarks of motor protein disruption in Drosophila and have been 
documented in the corpus collosum of mice believed to have defects in axon 
transport (Stokin et al., 2005). Therefore, it would be interesting to examine 
whether axon transport was defective in tamoxifen induced Lis1 knockouts. To do 
so, DRGs were isolated from adult triple mutant and CreERTM;R26GT control mice 
at 3 days following tamoxifen injection. DRGs were allowed to grow on laminin-
coated coverslips for another 24 hours. Lysotracker Red was added to the culture 
30min before live cell imaging. Membrane associated tomato fluorescence was 
almost gone 3 days after initial treatment. Axon processes can be visualized by 
GFP labeling via Cre activation. Lysotracker Red has strong red fluorescence 
that allows us to detect acidic organelles in axons. Time-laspe images were 
taken at 0.5s interval for 2 min. Kymographs were generated with Image J 
software(Figure 2.8A,B). Mice with floxed Lis1 and Cre showed significant 
reduction in percentage of acidic organelles undergoing retrograde transport 
compared to mice with wild-type Lis1, while there is no significant difference in 
anterograde transport with Lis1 perturbation(Figure 2.8C,D,E). The results are 








Tamoxifen inducible heterozygous Lis1 knockout mice do not show 
apparent behavior abnormality.  
Tamoxifen induced knockout double Lis1 alleles leads to progressive 
decline and ultimate death in adult mice. We asked whether conditionally 
knockout single copy of Lis1 in adult mice would result in different pathological 
consequences than double knockouts using floxed-lis1 and actin-Cre strains. 
Similarly, adult heterozygous inducible Lis1 knockout and control mice 
(heterozygous floxed Lis1 without Cre) were injected with 8mg tamoxifen for 2 
constitutive days. Heterozygous Lis1fl/+;CreERTM;R26GT mice did not exhibit 
apparent behavior abnormality. This is not surprising as conventional Lis +/- has 
much milder phenotype than homozygous Lis1 knockouts. What is interesting to 
us, is that analysis of Cre activity in brain tissues of these animals demonstrated 
homogenous strong GFP signal in the whole brain, coupled with dramatically 
reduced red fluorescence(Figure 2.9).  We then did a time-course analysis of Cre 
activation in brains. Three heterozygous inducible Lis1 knockouts were injected 
with high dose tamoxifen on the same day and were sacrificed individually on day 
2,day 7, and day 21 after initial treatment. In a preliminary study, saggital 
sections of brains from three animals revealed a gradual increase in the amount 








 Our study of the inducible Lis1 knockout mouse model demonstrates the 
importance of Lis1 in adult mammals. Tamoxifen induced Lis1 knockout using !-
actin Cre recombination system causes rapid death in adult mice. It is by far the 
first mouse model that studies the pathological consequences of loss of both 
alleles of Lis1 knockout in adult system. Although it is rather difficult to pin down 
the pathological causes of the lethal phenotype observed in tamoxifen induced 
Lis1 knockouts, we have provided several evidences that may be related to 
neuronal malfunction of cardiorespiratory control network in brainstem.  
 The death phenotype observed in tamoxifen induced Lis1 knockout mouse 
model is very consistent. Despite of difference in survival days, all the 
experimental mice showed sickness, underwent progressive decline and ultimate 
death, if not euthanized. Adult tamoxifen induced Lis1 knockout mice also 
exhibited ruffled up fur, hunched posture and leg clasping, indicating impaired 
locomotion and bad coordination(Connert et al., 2006). However, these severely 
and progressively disturbed neuromotoric functions were accompanied with the 
appearance of sings of illness and physical abnormalities observed in tamoxifen 
induced Lis1 knockout mice. It is possible that disturbed behavior is an indirect 
result of getting sicker and weaker rather than a direct consequence of loss of 
Lis1.  
 Examination of Cre activity in the brains of tamoxifen induced Lis1 
knockout mice revealed highest level of GFP expression in brainstem. The loss 
of Lis1 in brainstem becomes a possible cause of the lethal phenotype. The pre-
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Botzinger complex has been identified to be regulating the medullary respiratory 
network in mammals(Schwarzacher et al., 2011). The presumed pre-Botzinger 
complex is characterized by an aggregation of loosely scattered, small and 
lipofuscin-rich neurons, which contain neurokinin 1 receptor as well as 
somatostatin. The pathoanatomical studies support the view that disruption of the 
central respiratory network, including the pre-Botzinger complex, contributes to 
breathing disorders in multiple system atrophy such as Rett syndrome(Weese-
Mayer et al., 2006). A study revealed that selective lesions of the nucleus tractus 
solitarii lead to altered baroreflex control and to cardiac changes that may lead to 
sudden death(Talman and Lin, 2013).  Acute stroke can disturb central 
autonomic control, resulting in cardiac arrhythmias and ultimately sudden death. 
Evidence suggests that sudden deaths are probably due to an interaction 
between cardiovascular and neurological causes(Soros and Hachinski, 2012). 
 There are other possible neurological explanations for the death 
phenotype. For example, disruption of Lis1 in myelinating cells could alter 
neurotransmission. Acute-onset chronic inflammatory demyelinating 
polyradiculoneuropathy (A-CIDP) features multiple cranial nerve involvement, 
respiratory failure and skin manifestations(Hantson et al., 2010). Mutation in the 
tumor-suppressor phsophatase with tensin homology (PTEN) is associated with 
neurological abnormalities including autism, seizures and ataxia(Fraser et al., 
2004; Wei et al., 2006). Pten-deficient neurons in Pten conditional knockout mice 
revealed enlarged abnormal synaptic strucutres in the cerebral cortex and 
cerebellum. Severe myelination defects and weakened synaptic transmission 
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were observed in these mice(Fraser et al., 2008). Thus, it is possible that loss of 
lis1 causes defective myelination in cranial nerve, which results in impaired 
synaptic transmission in the cardiorespiratory control center. Cerebellar cells 
could also be involved in this network. 
 Astrocytes have been thought to be required for efficient functioning of 
respiratory neuronal network activity. Astrocytes have been reported to control 
breathing through pH-dependent release of ATP(Gourine et al., 2010). Cre 
activity detected in astrocytes in cortex suggests that loss of Lis1 in these cells 
may influence the homeostasis of the extracellular space that interfere with Ca+ 
concentration and neurotransmitter release. 
 In addition, we found that Lis1fl/fl;actinCreERTM;R26GT neurons in the 
brainstem region showed axonal pathology at 3 days following tamoxifen 
injection. There is a concern that we may have seen magnocellular neurons 
(large in diameter and spindle-shaped) in one brain section, while paraventricular 
neurons(small diameter and round-shaped) seen in the other section (Bader et 
al., 2012). However, note that in the chromatolysis analysis, the neurons we 
selected had similar size in diameter (Figure 2.6E).  Brainstem neurons display a 
prominent chromatolysis reaction, which is typical of axon injury(Hanz and 
Fainzilber, 2006). The RNA content and rate of protein production in cell bodies 
increase in response to axonal injury(Cragg, 1970; Lieberman, 1971).  The 
proposed mechanism is that the rapid ion influx at the injury site generates a 
number of electrophysiological response and the normal supply of retrogradely 
transported molecules such as trophic factor signals was interrupted. The 
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continuous supply of neurotrophic factors from axon terminals to the cell body is 
critical in maintenance and survival of specific populations of adult neurons (Hanz 
and Fainzilber, 2006). Recent studies indicate that in ALS, degeneration of 
motoneuron cell body is late in comparison to degeneration of axons. In the 
“acute” ALS group, enlargement of the tigroid has been occurring earlier than 
central chromatolysis. This phenomenon may be related to endoplasmic 
reticulum stress, disturbed axon transport or functional compensation of the 
neuronal deficit(Dziewulska et al., 2013). Thus, the chromatolysis occurring in the 
brainstem neurons from tamoxifen induced Lis1 knockout mouse suggests that 
axon damage or defects in axon transport has occurred in the brainstem of these 
mice.  
 Our results confirm that reduction of Lis1 in adult neuron causes axonal 
pathology and defective axon transport. We found that there was an overall 
increase in varicosities per mm of axon. Mice with floxed Lis1 and Cre showed 
significant reduction in percentage of acidic organelles undergoing retrograde 
transport compared to the control mice. Axonal defects have been noted in 
mouse model of Alzheimer’s disease. Similar axonal defects in the early stages 
of Alzheimer’s disease have also been seen in humans. It is reported that axonal 
swellings are consisted of accumulated abnormal amounts of microtubule-
associated and motor proteins, organelles, and vesicles. It is shown that 
reduction of kinesin motor protein impaired axonal transport, enhanced the 
frequency of axonal defects and increased amyloid-! peptide levels and amyloid 
deposition(Stokin et al., 2005). There is also evidence showing defective axon 
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transport of mitochondira, abnormal mitochondrial dynamic and synaptic 
degeneration in a mouse model of Alzheimer’s disease(Calkins et al., 2011). ALS 
is a fetal neurodegenerative disease, characterized by the loss of motor neurons 
in primary motor cortex, the brainstem, and the spinal cord, causing devastated 
basic, fundamental movements, such as breathing, and typically causes death in 
most cases(Kim et al., 2014). Deficit in axonal transport is a key pathogenic 
event in ALS and an early disease indicator of motor neuron 
degeneration(Bilsland et al., 2010). Brainstem is consisted of several types of 
motor neurons that are responsible for breathing and heart beating. Axonal 
defects we have seen in the brainstem and cultured DRG neurons of tamoxifen 
induced Lis1 knockout mice may indicate that the motor neurons in the brainstem 
undergo neurodegeneration due to Lis1 loss, which leads to neuronal misfunction. 
Another possibility we have not examined in these mice is defects in synapse 





Table 2.1 Characterization of phenotypes of inducible Lis1 knockout mice 
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Table 2.2 Characterization of phenotypes of inducible Lis1 knockout mice 
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+ Dead within 3 weeks 3/3 
+ Sick and euthanized by endpoint 3/3 





























Figure 2.1 Survival analysis of tamoxifen induced Lis1 knockout mice. A) 
Adult triple mutant mice at 8-week old injected on two consecutive days with 
tamoxifen (+Cre+TM) began to exhibit malaise on as early as the second day, 
with clearly ruffled coats and spinal kyphosis. They were hypoactive and did not 
respond to external stimuli. Control mice (-Cre+TM) showed wild type 
phenotypes. B) Kaplan-Meier survival curves showing cumulative morbidity -
percentage of mice showing sickness. In the initial studies experimental animals 
injected high dose tamoxifen (+Cre+8mgx2 TM) started showing sickness at day 
2 following the first injection (n=30). Experimental mice injected with low dose 
tamoxifen (+Cre+2mgx5 TM) did not exhibit apparent behavior changes until day 
5 (n=10). Control animals (-Cre) injected with tamoxifen did not show any signs 























Figure 2.2 High dose tamoxifen induced Cre activation in brainstem at 3 
days following initial treatment. A,B)Whole mount images of control mice  
Lis1fl/fl;R26GT) injected with 8mg tamoxifen for 2 consecutive days showed strong 
red fluorescence. C,D)  with no GFP expression in the brain. G,H) Examination of 
green fluorescence of whole brains from perfused animals indicated that Cre was 
strongly active in the brainstem, and cerebellum(under the same exposure time 
as controls. Much less GFP was apparent in the cerebral hemispheres at 3 days 





Figure 2.3 High dose and low dose tamoxifen induced Cre activation in 
brainstem at 5 days following initial treatment. A,B) An adult triple mutant 
mouse with vehicle injection(+Cre+vehicle) showed no green fluorescence 
background. C,D) The brain from an inducible Lis1 knockout mouse injected with 
high dose tamoxifen and sacrificed on 5th day showed strong GFP in brainstem 
and cerebellum. A few green cells were also detected in the cortex. Red 
fluorescence was greatly reduced in brainstem and cerebellum and remained 
high in cortex. E,F) Control brain( -Cre+2mgx5 TM) showed strong red 
fluorescence but no GFP expression. G,H) Low dose tamoxifen treated 
experimental animal (+Cre+2mgx5 TM) exhibited relatively low amount of GFP 








Figure 2.4 Cre activities were detected in cardiorespiratory control network 
in tamoxifen induced Lis1 knockout mice. A,B) Saggital sections of an 
inducible Lis1 knockout brain revealed significant amounts of GFP were present 
in brainstem and midbrain. Scattered green cells were observed in cortex and 
cerebellum under low magnification.(n=1) C,D) Activated fibers and axon 
projections were seen at pons under higher magnification(x40).(n=1) E) Coronal 
sections of brains identified the positions of activated neurons in these 
animals.(n=4) F) Confocal imaging of brainstem sections revealed that significant 
amounts of GFP were present in neurons in the brainstem, and also in neuropil 
and many fiber tracts. G) Diagram of a saggital brain section showing different 








Figure 2.4 J Coronal sections of brainstems from tamoxifen induced Lis1 
knockout mice. Brains were harvested from 4% paraformaldehyde perfused 
animals. Tissues were embedded in OCT and sectioned using cryostat. 10µm 
thick sections were collected and mounted on gelatin-coated slides. Images were 
taken by a dissecting scope attached with a CCD camera. Images show GFP 


















Figure 2.5 Lis1 expression level is reduced in brainstem of inducible Lis1 
knockout mice. A.) Extracts of brainstem, cerebellum, and cortex from 
tamoxifen treated of both floxed Lis1 with Cre transgene and floxed Lis1 without 
Cre mice were probed with polyclonal Lis1 antibody. Brain tissues were collected 
at 3 days following high dose tamoxifen injection. Lis1 expression level was 
found reduced in brainstems of floxed Lis1 with Cre animals compared to 
controls. No reduction of Lis1 levels in the cortex was detected from tamoxifen 
induced Lis1 knockouts at 2 days after initiation of treatment compared to floxed 
Lis1 without Cre. No difference of dynein expression level was detected in 
tamoxifen induced Lis1 knockout lysates compared to control ones. B.) Cortex, 
cerebellum and brain stem of experimental animal were collected at Day 5 
following tamoxifen treatment. Lis1 expression level was found reduced in 
brainstems and cerebellum of floxed Lis1 with Cre animals compared to controls. 
No difference of dynein expression level was detected in tamoxifen induced Lis1 
knockout lysates compared to control ones. C.) Quantification of Lis1 
expressions in the cortex, cerebellum, and brainstem from 4 animals of each 






Figure 2.6 Lis1fl/fl;actCreERTM;R26GT neurons in the regions of the nucleus 
ambiguous show axonal pathology at 3 days following tamoxifen injection. 
A.) Toluidine blue staining showed somal swelling, nuclear position, and Nissl 
substance dispersal in brain tissue. In tamoxifen treated experimental mice, 
nucleus of neurons in was displaced toward the periphery of the soma and the 
Nissl substance was significant reduced in the soma (thick arrows) . Brainstem 
sections were selected where nucleus ambiguus was present according to the 
mouse brain atlas. Comparison were made from matched sections. B.) Diagram 
shows a coronal section of mouse brain. The region analyzed was reticular 
formation where contain nucleus ambiguus. C.) Quantification of nuclear 
area/soma area in inducible Lis1 knockout mice and control mice. Neurons were 
scored as having nuclear eccentricity if the perpendicular distance from the NE to 
the somal edge at any point is less than half the perpendicular distance of the NE 
to the somal edge at any other point. Experimental mice had significant larger 
nucleus versus cytoplasm in brainstem. Measurements were from 50 neurons 
from 3 sections of 2 mice per genotype. Values are mean±SD. ***P<0.0001, 
student t-test D.) Quantification of the percentage of nuclear eccentricity 
observed in tamoxifen inducible Lis1 knockout mice and control mice. 
Measurements were from 50 neurons from 3 sections of 2 mice per genotype. 





















Figure 2.6 Lis1fl/fl;actCreERTM;R26GT neurons in the regions of the nucleus 
ambiguous show axonal pathology at 3 days following tamoxifen injection. 
E.) High magnification images of brainstem neurons from tamoxifen inducible 








Figure 2.7 Cultured DRG neurons from adult tamoxifen injected 
experimental animals, but not controls, show signs of axon pathology A.) 
Experimental animals showed GFP fluorescence after Cre induction, while only 
mTomato fluorescence was detected in control cells. Varicosities(large axon 
swellings at growth cones and axon terminal ends) were seen in the tamoxifen 
induced DRGs (white arrows). B) Several differences were found between GFP 
positive axons in from floxed Lis1 animals and Tomato positive axons from floxed 
Lis1 animals with no Cre. First the length of axon segments between branch 
points was shorter for GFP axons were shorter. Branch points were defined as a 
segment of axon between two adjacent growth cones. The first branch was 
counted from a leading process emerging from the cell body. C) There was an 
increase in the number of varicosities per branch point, and D) There is an 
overall increase in varicosities per mm of axon. Measurements were collected 
from 32 branches from 19 neurons of Lis1 knockouts and 30 branches from 9 






Figure 2.7 E.) Representative images of axon varicosities seen in inducible Lis1 
knockout and control mice. Much smaller swellings were seen in control 
neurons(short arrow). Only large swellings were counted as varicosities(long 










Figure 2.8 Lisfl/fl;actCreERTM;R26GT DRG neurons placed in culture after 
tamoxifen treatment show defective axonal transport. A,B) Retrograde 
transport was disrupted in mice with floxed Lis1 and Cre compared to mice with 
wild-type Lis1. C,D,E)There is significant reduction in percentage of acidic 
organelles undergoing retrograde transport compared to mice with wild-type Lis1, 
while there is no significant difference in anterograde transport with Lis1 
perturbation. Measurements were collected from 24 axons of 3 sets of animals 
per genotype. Anter: the numbers of organelles that moved toward the cell body,  
Retro: away from the cell body, Both: bi-directionally, Static: made negligible 
moves in either direction.Values are mean±SD. Turkey’s multiple comparison test 











Figure 2.8 Lisfl/fl;actCreERTM;R26GT DRG neurons placed in culture after 
tamoxifen treatment show defective axonal transport. F.) Representitive 
images of kymographs showing transport data in mice with floxed Lis1 and 












Figure 2.9 Heterozygous Lis1fl/+;CreERTM;R26GT mice did not exhibit 
apparent behavior abnormality. Analysis of Cre activity in brain tissues of these 
animals demonstrated homogenous strong GFP signal in the whole brain, 

























Figure 2.10 Time-course analysis of Cre activation in brains. Three 
heterozygous inducible Lis1 knockouts were injected with high dose tamoxifen on 
the same day and were sacrificed individually on day 7, and day 21 after initial 
treatment. Saggital sections of brains from three animals revealed a gradual 









THE EFFECT OF AN INDUCIBLE ACTIN-CRE DOUBLE LIS1 KNOCKOUT IN NON-











Analysis of the actin-Cre driven inducible Lis1 knockout in an adult mice 
model suggested a previously unidentified but essential role of Lis1 in adult 
mammalian system, particularly in maintaining normal neuronal function. We 
have identified evidence of correlations between loss of Lis1 in brainstem and 
axon defects in tamoxifen induced Lis1 knockout animals. However, whether 
reduction of Lis1 expression level and the subsequent neuronal pathology in 
cardiorespiratory center in brainstem directly lead to the lethal phenotype 
observed in adult mice remains unclear. We could not rule out the possibility that 
loss of Lis1 upon Cre activation in other tissues such as hearts, lungs, liver etc 
could contribute to the death phenotype in tamoxifen inducible Lis1 knockouts 
since !-actin Cre drives Cre expression in most tissues throughout the whole 
body. Thus, it would be necessary to examine Cre activity in other tissues 
besides brains.  
 Although Lis1 expression level is very low in non-neuronal tissues, 
knockdown of Lis1 in life-threatening organs such as hearts could conceivably 
lead to ultimate death phenotype in adult mice. Besides its critical role in 
regulating neuronal functions in embryonic brain development, Lis1 is also 
involved in regulating other important cell functions. A lot of these regulations 
involve the interaction between Lis1 and a microtubule motor, dynein. The levels 
of Lis1 alter the distribution of dynein IC in Cos-7 cells and Lis1+/- fibroblasts 
exhibit microtubule organization(Smith et al., 2000). Lis1 has also been 
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implicated in mitotic spindle orientation and chromosome segregation, defects in 
which, in turn, affect mitotic progression (Faulkner et al., 2000). In mammalian 
cells, dynein/dynactin recruits Lis1 to kinetochores. Lis1 regulates 
dynein/dynactin binding to microtubule (MT)(Coquelle et al., 2002; Tai et al., 
2002). Interaction between Lis1 and dynein heavy chain is important for 
membrane transport and possibly other cellular activities(Liang et al., 2004). 
Invitro studies showed that Lis1 reduced microtubule catastrophe events, and its 
interaction with the cytoskeleton may be transducing a signal pathway(Sapir et al., 
1997). The yeast homologue of Lis1,Pac1p has been shown to interact with a 
ubiquitin ligase(Alonso et al., 2012) 
To date, there are only a few studies investigating roles of Lis1 in non-
neuronal system. The epidermal-specific loss of Lis1 results in dramatic defects 
in microtubule reorganization. Lis1 ablation also causes desmosomal defects, 
which contributes to loss of epidermal barrier activity, resulting in completely 
penetrant perinatal lethality(Sumigray et al., 2011). A most recent study 
demonstrated that Lis1 is critically required for hematopoietic stem cell function 
and leukemogensis. Conditional deletion of Lis1 in the hematopoietic system led 
to a severe bloodless phenotype, and embryonic lethality(Zimdahl et al., 2014). 
Conditional deletion of Lis1 in developing hair cells causes defects in cytoplasmic 
dynein and microtubule organization, resulting in planar polarity defects without 
overt effects(Sipe et al., 2013). Although limited, these observations from Lis1 
knockout mouse model suggest that Lis1 disruption in other tissues could result 
in defective organ functions.  
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Although we do not expect loss of Lis1 in non-neuronal adult tissue would 
lead to severe phenotypes given its relatively low expressions, if it does so, it 
would be a previously unidentified yet critical role of Lis1 in adult organs besides 
the brain. 
 In this chapter, we examined Cre activity in various tissues in inducible 
adult Lis1 knockout mice. Cre activity was found most abundantly in the heart 
and skeletal muscle, which are relevant to high expression of !-actin in these 
tissues. We also analyzed changes of Lis1 expression levels in multiple tissues 
of tamoxifen induced Lis1 knockouts. Significant reduction of Lis1 in adult heart 
prompted us to generate an inducible cardiomyocyte- specific Lis1 knockout 
mouse model. The alpha-MHC-MerCreMer transgene has the mouse cardiac-
specific alpha-myosin heavy chain promoter (Myh6) directing expression of a 
tamoxifen-inducible Cre recombinase to adult cardiac myocytes. Mice 
homozygous for the Myh6 transgene are viable and fertile prior to tamoxifen 
administration. Lexow et al reports that a single tamoxifen injection (40mg 
tamoxifen/kg body weight) resulted in th uniform recombination in cardiomyocyte 
fibers without the cardiomyopathological effects. (Lexow et al., 2013)One week 
following tamoxifen injection, Cre activation detected by scattered !-gal 
expression was observed in atria, and homogenous expression in 
ventricles(Sohal et al., 2001).  Driving Cre expression specifically in the heart 





3.2 MATERIALS AND METHODS: 
Mouse breeding and colony maintenance 
All the mice used in this project were maintained at the animal research facility in 
The University of South Carolina. The experimental protocols have been 
approved by the animal use protocol (AUP) committee. All the transgenic mice 
and knockout mice were maintained on its original genetic background. However, 
when generating inducible Lis1 knockout mice by crossing three different mouse 
strains, mixed genetic background could not be avoided. To minimize variation in 
the genetic background, the males (Lis1fl/fl;myh-6-CreERTM; R26GT) and 
famales (Lis1fl/fl;R26GT) from the same generation were crossed to produce 
inducible Lis1 knockout mice, and mice from the same litter were compared. 
However, in order to gather enough samples for statistical analysis, tissues from 
different animals with the same genotype at different ages were pooled.  
Mice were marked by ear puncture at weaning (3-4 weeks old), and genomic 
DNA was extracted from tail for routine genotyping.  
 
1.2.3 Genotyping: 
Primers for genotyping heart-specific Cre are the same as universal Cre. Mice 
tails were digested in Tail buffer plus Protease K overnight at 55 oC. 2µl of tail 
digest was used as DNA templates for PCR reaction. Primers for Lis1 flox/flox: 
Sequence5'->3' TGA ATG CAT CAG AAC CAT GC; CCT CTA CCA CTA AAG 
CTT GTT C. Primers for Cre : Sequence5'->3' CTA GGC CAC AGA ATT GAA 
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AGA TCT; GTA GGT GGA AAT TCT AGC ATC ATC C. Primers for R26GT : 
Sequence5'->3' CTC TGC TGC CTC CTG GCT TCT; CGA GGC GGA TCA CAA 
GCA ATA ; TCA ATG GGC GGG GGT CGT.  
A standard PCR reaction was set up as followed: For each tail DNA sample, to 
make 25µl total volume, 6.5µl of H2O, 5.5 µl Master Mix 2.5µl each primer and 
2µl Tail DNA were added to PCR tubes. The reaction was performed on a PCR 
thermocycler as follows: 94oC for 3 min for hotstart; 94 oC for 30s, 60 oC for 1 
min, 72 oC for 1min. Repeat steps above for 35 cycles. 10µl of the reaction 
product was run on 5% polyacrylamide gel at 120V for 30 min. Gel was stained 
with EB for 10min. DNA bands could be detected under UV light. 
 
TM injection and Cre activation 
We used the same amount of tamoxifen to induce Cre-mediated recombination in 
heart specific Lis1 knockout mice as the universal Cre. Tamoxifen (Sigma-
Aldrich) was dissolved in corn oil (Sigma-Aldrich) at a concentration of 40mg/ml 
and administered to 2 month-old Lis1fl/fl; myh6-CreERTM; R26GT at 8mg/day for 2 
days depending on the experiment settings. Water and food were available ad 
libitum.  
 
Tissue preparation and Histology. 
Animals were deeply anesthetized with isofluorane administration and perfused 
transcardially with ice-cold PBS first, followed by 4% paraformaldhyde (PFA) in 
0.1M PBS, pH7.4. For whole-mount organ analysis, organs were isolated and 
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imaged with a CCD camera mounted on a fluorescence microscope(Olympus). 
For cryosection preparation, brains, hearts, lungs, livers and other tissues were 
removed and postfixed in 2% PFA+15% sucrose solution prepared in PBS 
overnight and subsequently cryoprotected by incubation in 30% sucrose solution 
for 3-4 hours at room temperature. The cryoprotected brains were submerged in 
OCT Compound solution  and quickly frozen in 2-methylbutane cooled in liquid 
nitrogen. Sagittal or coronal sections were cut at a 10-µm thickness on a cryostat 
(Leica) and stored at -80oC before used. Slides were washed three times with 
PBS, treated with DAPI (Molecular Probes), washed again, mounted in anti-fade 
reagent (Invitrogen) and imaged with fluorescence microscopy (Zeiss) or 
confocal microscopy (Leica).  
 
Immunoblotting 
The levels of Lis1 protein was evaluated in Lis1 CKO and age-matched control 
mice by immunoblotting. Mice were deeply anesthetized and decapitated, and 
the brains and other tissues were removed quickly and frozen on dry ice. Tissue 
samples were homogenized with Dounce’s homogenizers in ice-cold RIPA buffer 
with protease inhibitors. Crude homogenates were sat on ice for 20 minutes and 
then centrifuged at 20,000 g for 1 hour (4oC) to yield soluble supernatant and 
pellet fractions. Protein concentrations were measured by BCA assay (Thermo 
scientific) with bovine serum albumin as a standard. Protein samples were 
subjected to 10% SDS-PAGE and transferred to PVMF membrane. Blots were 
blocked with 5% nonfact dry milk with 0.1% Tween 20 in PBS and then incubated 
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overnight at 4oC with antibody to Lis1 or dynein intermediate chain(). After the 
primary antibody incubation, blots were washed and incubated with horseradish 
peroxidate-conjugated secondary antibody, developed with enhanced 
chemiluminescence(Millipore) and exposed to x-ray film. 
To quantify protein immunoreactivity, films were scanned and densitometry was 
performed using image J. Protein levels were expressed as relative optical 
density measurements. Immunodensities were normalized to control proteins.  
 
Immunostaining 
Neurons were plated onto 12mm coverslips in 24-well plates. Neurons were fixed 
in 4% paraformaldehyde followed by permeabilization with 0.1% Triton X-100 for 
5 min at room temperature. Nuclei were visualized with Hoechst  and coverslips 
were mounted on glass slides using ProLong Gold Antiface reagent (Invitrogen). 
Neurons were observed using an inverted microscope (Axiovert 200, Carl Zeiss 
Inc.) equipped with Plan-Neo 100x/1.30 objective and a Plan-Apo 63X/1.40 
objective. Digital images were acquired using a charge-couple camera ( AxioCam 










Mosaic Cre activity was detected in non-neuronal tissues of inducible !-
actin Cre Lis1 knockout mice 
The fluorescent images of whole mount organs showed strongest GFP levels in 
heart tissue, while relatively low level of Cre recombination detected in liver at 3 
days following tamoxifen injection. At Day 5, an increase in Cre activation 
indicated by homogenous green fluorescence detected in the heart and lung, but 
GFP level in liver remained low at this point (Figure 3.1). Tissue sections of 
tamoxifen induced Lis1 knockout mice revealed a subset of cells were activated 
in the heart, lung, liver and kidney(Figure 3.2). These observations are consistent 
with the original report of actin-Cre ER mouse model that Cre activities in multiple 
tissues were highly mosaic, with the highest recombination efficiency detected in 
highly vascular tissue like the heart. The GFP expression patterns detected in 
lung, liver and kidney suggest that Cre was activated in a certain type of cells. 
Whether these cells have more !-actin expression than others that do not show 
green remains unclear. Tissue sections of tamoxifen injected control mice do not 
have GFP expression in all organs. 
 
Tamoxifen induced cardiomyocte-specific Lis1 knockout mice do not 
exhibit aberrant phenotype 
Although there is significantly less Lis1 in these tissues normally, the death of 
knock out animals suggested the possibility that Lis1 loss in the heart itself could 
result in cardiac failure. To test this directly we crossed our double floxed 
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Lis1/Cre-reporter mice with a mouse in which Cre-ER expression driven by a 
myosin heavy chain (MHC6) promoter and is restricted to cardiomyocytes. 
Generated heterozygous floxedLis1;myh-6-Cre;R26GT were backcrossed with 
double floxed Lis1;R26GT to obtain homozygous floxed Lis1;myh6-Cre;R26GT 
mice. Mice harboring double floxed Lis1;R26GT; but no myh-6-Cre served as 
control ones(Figure 3.3). Experimental and control mice were injected with 8mg 
tamoxifen for two consecutive days. Interestingly, none of the floxed Lis1 animals 
showed any overt behavior abnormality following tamoxifen injection (n=6). Lis1 
expression level was examined by western blot and found reduced in heart tissue. 
Fluorescence images of whole tissue revealed strong GFP expression in cardiac 
muscle, with significant red fluorescence reduced. No Cre activation was 
observed in the whole brain including brainstem in this heart-specific Lis1 
knockout mouse model(Figure 3.4). This strengthened the hypothesis that the 
death phenotype was caused by Lis1 loss in neurons of the cardiorespiratory 
brainstem network. However, it remains possible that loss of Lis1 in other cell 
types in the mouse could contribute to the severe phenotype of Lis1 knockout.  
 
Comparison of Lis1 expression patterns in multiple tissues of low-dose and 
high-dose tamoxifen induced Lis1 knockout mice 
         Analysis of multiple tissue sections revealed that Cre activity was present in 
non-neuronal tissues as well as brains. However, the degree of Cre activation 
upon tamoxifen injection varies between tissues. Additionally, low-dose tamoxifen 
treated Lis1 knockout mice survived longer than high-dose tamoxifen treated 
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ones. We know this difference in survival is not due to the direct effect of 
tamoxifen as actin-CreERTM;R26GT mice with wild-type Lis1 treated with 
tamoxifen do not have detectable behavior abnormality. It may reflect different 
changes in Lis1 expression patterns in various tissues, which in turn, may result 
in different phenotypes or distinct timings of disease progression in adult mice. 
Thus, it would be interesting to compare Lis1 levels in various tissues of low-dose 
and high-dose tamoxifen induced Lis1 knockout mice. We compared changes in 
Lis1 expression patterns in low-dose and high-dose tamoxifen treated animals. 
High dose tamoxifen treated animals showed severe malaise on day 5 following 
initial treatment. Low-dose treated animals did not exhibit any behavior 
abnormality on day 5. Tissues were collected on day 5 to examine changes of 
Lis1 levels. We found that there was a significant reduction in Lis1 level in 
brainstem from high-dose treated experimental mice compared to the control, 
while low-dose treated animals did not have Lis1 reduction in brainstem on day 
5(Figure 3.5). Consistently, there was a Lis1 reduction in tamoxifen treated 
hearts in both low dose and high dose cases. However, dynein and tubulin 
expression levels were very low in the heart, suggesting Lis1/dynein pathway in 
the heart may not be as important as it is in the brain. All of these suggest that 
loss of Lis1 in brainstem may be the cause of lethal phenotype observed in 
tamoxifen induced Lis1 knockout mice. 
           High dose tamoxifen treated experimental mice die within one week 
following initial injection. Most of them showed severe malaise and were about to 
die by the endpoint that we euthanized and harvested the tissue for further 
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analysis. Among those, there was one mouse that showed milder phenotype than 
other experimental mice. It exhibited leg clasping during tail suspension test, 
however, it did not have other symptoms such as kyphosis, difficulties walking 
and breathing like other experimental mice did. Low dose tamoxifen treated 
experimental mice did not show aberrant phenotype on day 5 following initial 
injection. We harvested tissues from the high-dose treated mouse that showed 
milder phenotype and compare them to the tissues from the low-dose treated 
experimental mice. Tissue lysates were probed with polyclonal Lis1, GFP and 
tubulin antibodies. After normalizing to tubulin, western blot showed that there is 
a small decrease (~24.7%) in Lis1 in the cortex of high-dose treated animal 
compared to the control, while there was no difference in between low-dose 
treated animal and the control(Figure 3.6). Interestingly, both in low-dose and 
high-dose treated animals, there were dramatic decreases of Lis1 level in hearts. 
There was a small reduction in the high-dose treated lung compared to the 
control. No difference in tamoxifen treated liver tissues compared to control 
livers. These results suggest that reduction of Lis1 level in cortex may result in 
behavior abnormality seen in this animal. However, Lis1 reduction in the heart 
and the lung did not result in severe phenotype that leads to death observed in 
other tamoxifen induced Lis1 knockout mice. GFP expressions in the tamoxifen 
induced Lis1 knockout tissues are consistent with fluorescent images of tissue 





Cre activation in diaphragm and skeletal muscle tissues   
            Heart specific Lis1 knockout mice did not show any obvious behavior 
abnormality compared to wild type mice. It suggests that loss of Lis1 in heart 
does not cause death phenotype. Other possible causes of lethal problems 
include defects in diaphragm that supports regular breathing. Evidence showed 
that there was no significant loss of motor neurons or dorsal root ganglia sensory 
neurons, but a decrease in complexity of neuromuscular junctions(Courchesne et 
al., 2011). We then examined Cre activity in diaphragm and other skeletal 
tissues. We detected strong GFP expression in diaphragm and thigh muscle, 
which is rich in !-actin(Figure 3.7A). However, Lis1 expression in diaphragm is 
almost undetectable compared to its levels in brains and hearts even after 
overnight exposure(Figure 3.7 B).  
 
3.3 DISCUSSION: 
       The pathological causes of the lethal phenotype seen in tamoxifen induced 
Lis1 knockout mice are largely unknown. A critical question is whether the 
pathological consequences arise from the brainstem neuron itself or from non-
neuronal cells. Mosaic Cre activity was detected in non-neuronal tissues of 
inducible !-actin Cre Lis1 knockout mice with high level in the heart. Heart failure 
is one of the possible reasons that can account for the lethal phenotype. 
Tamoxifen induced heart specific Lis1 knockout mice did not exhibit any 
observable behavior abnormality as it is seen in the !-actin Cre inducible Lis1 
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knockout mice. Given the fact that myh6-Cre only drives Cre activation in 
cardiomyctes, we cannot rule out the possibility that loss of Lis1 in other heart 
cells such as neural crest cells may affect the phenotype in adult mice. 
Additionally, the original myh6-Cre mouse strain is in B6.FVB(129) mixed 
background, which may also impact the phenotype observed in these mice. 
There is no literature that described the role of Lis1 in heart development so far. 
However, there is a link between Lis1 being a target of miR302/367 and lung 
development. Lis1 is essential for proliferation and the precise control of mitotic 
spindle orientation in both neuroepithelial stem cells and radial glial progenitor 
cells (Yamada et al., 2010; Yingling et al., 2008). Downregulation of miR302/367 
in transgenic lung endoderm displayed a disorganized apical layer. Lis1 was 
found to be associated with miR302/267 for establishment of proper apical-basal 
polarity of a single-layered endoderm(Tian et al., 2011). However, again, these 
findings are done in the context of developmental stage. No direct link between 
Lis1 level and lung function in the adult system has been identified so far.  
 Western blot analysis of Lis1 levels in various tissues of the tamoxifen 
induced Lis1 knockout mouse that had much milder phenotype showed highest 
GFP expression level and significant reduction in the heart compared to other 
tissues. This suggests that reduction of Lis1 in hearts is not likely to result in the 
lethality phenotype observed in !-actin Cre Lis1 knockout mice. We also did 
western blot analysis of Lis1 levels in a tamoxifen induced Lis1 knockout mouse 
that had severe malaise. It showed that there was a significant reduction of Lis1 
in brainstem, while only a slight decrease in other tissues. This preliminary result 
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strengthens our hypothesis that the death phenotype is resulted from loss of Lis1 
in brainstem. However, due to the technical difficulty of harvesting multiple 
tissues from 4 different treatment groups at one time, a more systematic and 
detailed tissue analysis will be needed to further confirm the changes of protein 
levels in various tissues upon Cre induction. Percentage of Lis1fl/fl;Cre 
recombination can also be measured at DNA level using quantitative PCR 
amplification of Lis1fl/fl allele from genomic DNA isolated from each tissue. 
Alternatively, changes in mRNA level can be used to estimate the recombination 
efficiency in various tissues. 
          The reasons of death phenotype in the inducible Lis1 knockout mouse can 
not be certain because !-actin Cre is ubiquitously expressed, and many tissues 
can be affected. Another possibility we have not discussed above is respiratory 
muscles, like diaphragm. Analysis of Cre activity showed strong GFP expression 
in diaphragm and other skeletal muscle. Defects in neuromuscular junction in the 
diaphragm could be correlated with breathing defects that may be responsible for 
death of the inducible Lis1 knockout mice. However, Lis1 expression in 
diaphragm is undetectable compared to it is in the brain and the heart. 
Furthermore, low levels of Cre activity were also detected in the liver and kidney 
of tamoxifen induced animals. Given the fact that Lis1 plays a important role in 
mitosis and dynein-dependent receptor recycling and vesicle transport, loss of 
Lis1 in liver and kidney may affect hormone metabolism through signaling. 










Figure 3.1 The fluorescent images of whole mount organs. A,B,C) No green 
fluorescence was detected in heart, lung and liver of a control animal(-Cre_ 
injected with tamoxifen. D,E,F) The fluorescent images of whole mount organs 
showed strongest GFP levels in heart tissue, while relatively low level of Cre 
recombination detected in liver at 3 days following tamoxifen injection. G,H,I) At 
Day 5, an increase in Cre activation indicated by homogenous green 
fluorescence detected in the heart and lung, but GFP level in liver remained low 












Figure 3.2 Cre activations in various tissue sections. A,B,C,D)Tissue 
sections of control mice(-Cre) injected with tamoxifen showed no GFP expression 
in heart, lung, liver and kidney. E,F,G,H)Tissue sections of tamoxifen induced 
Lis1 knockout mice revealed a subset of cells were activated in the heart, lung, 
liver and kidney. Shown are cardiac muscle(E), lung alveoli (F), liver hepatocytes 















Figure 3.3 Tamoxifen induced cardiomyocyte-specific Lis knockout mice. 
A.) Three mouse strains were used to generate cardiomyocyte-specific Lis1 
knockout mice. B.) We crossed our double floxed Lis1/Cre-reporter mice with a 
mouse in which Cre-ER expression driven by a myosin heavy chain (MHC6) 
promoter and is restricted to cardiomyocytes. Generated heterozygous 
floxedLis1;myh-6-Cre;R26GT were backcrossed with double floxed Lis1;R26GT to 
obtain homozygous floxed Lis1;myh6-Cre;R26GT mice. Mice harboring double 






























Figure 3.4 Cre activation in cardiomycyte-specific Lis1 knockout mice 
A.) Fluorescence images of whole tissue revealed strong GFP expression in 
cardiac muscle, with significant red fluorescence reduced. No Cre activation was 
observed in the whole brain including brainstem in this heart-specific Lis1 
knockout mouse model. B.) Lis1 expression level was examined by western blot 
and found reduced in heart tissue. C.) Quantification of Lis1 expressions in the 






















Figure 3.5 Changes in Lis1 levels of tissues from low dose and high dose 
treated animals.  A.) Tissues were collected on day 5 to examine changes of 
Lis1 levels. There was a reduction in lis1 level in brainstem from high-dose 
treated experimental mice compared to the control, while low-dose treated 
animals did not have Lis1 reduction in brainstem on day 5. Consistently, there 
was a Lis1 reduction in tamoxifen treated hearts in both low dose and high dose 
cases. B.) Quantification of Lis1 expressions in the brainstem and heart from 3 
animals of each treatment per genotype. BS: Brainstem, HT: Heart. Low: 2mg 


























Figure 3.6 Lis1 expression level changes in tissues from low dose and high 
dose treated animals. A) There was a small reduction in the high-dose treated 
lung compared to the control. No difference in tamoxifen treated liver tissues 
compared to control livers. B) Western blot of kidney and diaphragm from low-
dose/high-dose tamoxifen treated animals. 30µg protein extracts were loaded on 
each lane. There was a reduction of Lis1 in high-dose treated kidney compared 
to the control. However, there was no detectable Lis1 present in diaphragm. 


















Figure 3.7 Cre activities in diaphram and skeletal muscle. A) Strong GFP 
expression was detected in diaphragm and thigh muscle, which are rich in !-
actin. B) Lis1 expression in diaphragm is almost undetectable compared to its 
levels in brains and hearts even after overnight exposure. C) Quantification of 
Lis1 expressions in the brain, heart and diaphragm from 3 control animals (-Cre). 



























 LIS1 is the gene that encodes for the ! subunit of platelet-activating factor 
acetylhydrolase (PAFAH1B1). Heterozygous mutation or deletion in LIS1 causes 
a severe developmental brain disorder, lissencephaly in humans. Homozygous 
null mice die early in embryogenesis, while mice with one inactive allele 
displayed brain disorganization. Moreover, Lis1 has been shown to be regulating 
dynein dependent organelle transport. In this study, the effect of Lis1 knockout in 
adult mammalian system has been investigated using a tamoxifen inducible 
knockout mouse model directed by !-actin Cre. Loss of Lis1 in adult mice caused 
a progressive decline and ultimately death. These phenotypes were not observed 
in any of a variety of control animals. Analysis of Cre activity revealed it was not 
uniformly stimulated in all regions of the brain, and is highest in the brainstem, 
where neuronal processes in regions known to control cardiorespiratory networks 
were activated. Deletion of lis1 in hearts did not seem to induce lethality or 
malaise in adult mice. This strengthened the hypothesis that the death phenotype 
may be caused by Lis1 loss in neurons of the cardiorespiratory brainstem 
network. Analysis of brain sections and cultured sensory neurons from adult 
tamoxifen injected experimental animals revealed axonal pathology and defective 
axon transport. However, due to the ubiquitous expression pattern of Cre, we 
could not rule out the possibility that loss of Lis1 in non-neuronal tissues may 
contribute to the death phenotype observed in tamoxifen induced Lis1 knockout 
mice. We have noted that some of the tamoxifen induced Lis1 knockout mice had 
wet fur and enlarged abdomen. Whether these symptoms occur frequently still 
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needs further examination. This may suggest a bladder and gut dysfunction, 
which are components of autonomic functions.     
 By controlling the site of drug delivery, !-actin Cre allows spatial 
modulation of gene activity. In this case, 4-OH tamoxifen can be sterotaxicically 
injected in the region of mouse brainstem to knockout Lis1 in mice. Alternatively, 
recombinant adenoassociated viral (rAAV) vectors expressing Cre recombinase 
can be microinjected into distinct mouse brain regions to selectively knockout 
Lis1(Schierberl and Rajadhyaksha, 2013). However, sterotaxical injection of 
tamoxifen in the mouse brain may not activate the same subset of neurons that 
are expressing GFP upon IP injection. If loss of Lis1 specifically in brainstem 
causes lethality in adult mice, it will suggest that depletion of Lis1 in brainstem 
dramatically alters the neuronal function, which may lead to devastating 
consequences. 
 Although we have provided some information on low-dose tamoxifen 
induced Lis1 knockout mice, further experiments will be needed to characterize 
the phenotype with loss of Lis1. Moreover, adjusting the dosage of tamoxifen 
injected in the animal, we can generate different levels of mosaicism which would 
result in different phenotypes(Espinosa et al., 2014). By identifying regions that 
have undergone the recombination, the role of Lis1 in these regions can be 
investigated. Low doses of TM induce recombination in a small set of cells, which 
may circumvent the lethality observed in high dose tamoxifen induced Lis1 
knockout mice.  
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 Because its essential roles in brain development, the majority of Lis1 
mutant mice generated have been aimed at elucidating the effects of Lis1 
depletion during developmental stage. Our inducible Lis1 kn#ckout mouse is one 
of the few mouse models that studied the role of Lis1 in mature mammalian 
system. The progressive decline and lethal phenotype is unexpected but 
interesting. Axonal pathology observed in presumably motor neurons in 
brainstem indicated the possible link between neuronal dysfunction and 
disruption of Lis1/dynein pathway. Given the fact that Lis1 is a dynein regulator, 
mutation in dynein heavy chain result in progressive motor neuron degeneration 
in heterozygous animals(Andersen, 2003). Defects in dynein dependent axon 
transport have been linked to motor neuron degeneration in mice. Thus, it will be 
reasonable to examine how loss of Lis1 alters Lis1 and dynein interactions, 
distribution or activity under pathological conditions. Potential changes in 
interacting proteins can be monitored by IP-Western with the 74.1 DIC antibody. 
We can also determine if dynein is more or less likely to co-pellet with 
microbubules from inducible Lis1 knockout brain. 
 There are several limitations in the current study. First, although Lis1 
protein decrease has been demonstrated by western blot in the whole brainstem 
of mutant mouse, a more detailed description for the specific cell types affected 
by Lis1 knockout in adult mice has not been examined. This should have been 
achieved by immunostaining on tissue sections, however, the Lis1 antibody used 
in the current study is not suitable for immunostaining on tissue sections. 
Therefore, the pattern of Lis1 knockout is demonstrated indirectly by GFP 
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expression of R26GT transgene. For future study, we can use a commertially 
available Lis1 antibody H300, a rabbit polyclonal IgG to accurately examine Lis1 
expression in various tissue. Secondly, the axon transport study was only 
performed on cultured sensory neurons which may not provide direct information 
on the effect of loss of Lis1 on motor neurons in brainstem. It is difficult to do 
transport study on tissues. However, an approach has been established to allow 
single cargo analysis in motor axons in situ. By utilizing a Thy1-MitoCFP 
transgenic mouse which selectively labels neuronal mitochondria,  the flux of 
fluorescently labeled mitochondria could be measured in intercostal nerves in 
trangularis sterni nerve muscle explants(Bilsland et al., 2010; Marinkovic et al., 
2012). In addition, axonal morphology in brain tissues has not been examined in 
this study. In human neurodegenerative disorder dystrophic neurites are filled 
with autophagic vacuolar structures that can be visualized by electron 
microscopy(Nixon, 2007). Developmental Lis1 heterozygosity resulted in 
changes in dendrites in the adult hippocampus, but it was not clear whether this 
reflected a developmental defect or a later onset event(Fleck et al., 2000). We 
can compare dendritic arbors in inducible Lis1 knockout and control mice using 
Golgi Staining. Thirdly, the ultimate death of the inducible Lis1 knockout mouse 
prevents further analysis at later stages. Thus, other Cre lines with more specific 
expression pattern could be considered in future. For instance, the Camk2a-
Cre/ESR1 strain, available through the European Mouse Mutant Archive, carries 
an inducible Cre recombinase under the control of regulatory elements of the 
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CAMK2a gene, would permit analysis of neuronal effects in the cortex and 
hippocampus. 
 The current study exploits the technique of tamoxifen inducible knockout to 
study the role of Lis1 in adult mammalian system. To our knowledge, this is the 
first study that investigates the effects of deletion of double alleles of Lis1 in adult 
system using a inducible knockout mouse model. The findings from this study 
demonstrate the importance of Lis1 in adult mammals. We provide a novel model 
system to explore the function of Lis1 in intact animals and a model for potential 
therapeutic intervention to counteract symptoms of lissencephaly that may arise 
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